comprehensive -WSS

comprehensive

author：explore 2025-10-03 00:08:00 - browse：1

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Petition to FDA: Get the lead out of consumer hair dyes

entertainment

WSS

What to know about OceanGate, the company behind the missing Titanic submersible

Palantir health business leans on meeting customers’ needs

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Grail spinoff by Illumina should end disastrous merger attempt

Wikipedia

comprehensive

focus

Medical records are filled with copy

Leqembi, other new Alzheimer’s drugs require better biomarkers

Supreme Court strikes down use of affirmative action

Violet CEO on training clinicians to promote more inclusive care

23andMe had bad news about my health. I wish a person had delivered it

How to keep neuroscience’s past racism from being its future

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What STAT readers think about the FDA and patient advocacy

In age of alternative facts, a scholarly course on calling out crap

What STAT readers think about the FDA and patient advocacy

focus

Medicare drug price negotiation hasn't dried up venture capital

Three trends to watch in biotech in 2024

Iowa House, Senate pass 6

Elizabeth Holmes on track for early release from her 11

Medicare drug price negotiation hasn't dried up venture capital

Palantir health business leans on meeting customers’ needs

Wikipedia

Wikipedia

entertainment

Wikipedia